哺乳動物蛋白市場規模、佔有率和成長分析：按蛋白質類型、來源、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球哺乳動物蛋白市場價值為 21.8 億美元，預計到 2025 年將成長至 23.7 億美元，到 2033 年將成長至 46.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.7%。

全球哺乳動物蛋白市場以牛血清白蛋白、膠原蛋白和免疫球蛋白等畜牧來源蛋白為主要特徵。這些蛋白質因其與人體生化特性高度相容，在製藥、診斷和細胞培養基領域中發揮著至關重要的作用。與重組蛋白相比，這種相容性使其療效更佳，免疫抗原性也更低。該市場曾一度局限於學術領域，但如今已顯著擴張，這主要得益於純化技術的創新和生物製藥需求的成長。生物製藥的快速發展增加了對無血清、高度動物相容性培養基的需求，從而提高了膠原蛋白和白蛋白等關鍵蛋白的產量。這反過來又降低了生產成本，加快了癌症治療產品的上市速度，刺激了再生醫學領域的投資，並進一步推動了市場成長。

全球哺乳動物蛋白市場的成長要素

消費者對兼具基本營養價值和健康益處的蛋白質來源的需求日益成長。他們尋求能夠促進肌肉恢復、增強免疫功能並提升飽足感的蛋白質。哺乳動物蛋白以其全面的氨基酸組成和生物活性胜肽而聞名，能夠滿足消費者的這些期望，並擴大被添加到各種產品中，包括點心棒、乳製品替代品和強化飲料。這一趨勢正在推動產品創新，拓展分銷網路，並最終促進銷售成長，因為品牌可以利用這些蛋白質的附加價值和功能優勢，在競爭激烈的市場中脫穎而出。

全球哺乳動物蛋白市場限制因素

全球哺乳動物蛋白市場面臨許多阻礙，主要地區監管機構實施的嚴格法規對其造成了嚴重限制。這些法規旨在保護公眾健康並維護道德標準，並專注於安全性、標籤和動物福利。製造商必須投入大量時間和資源進行廣泛的檢驗測試、可追溯性文件編制和定期審核。這不僅延長了產品上市時間，也增加了營運的複雜性。此外，監管變化帶來的不確定性可能會阻礙新產品上市，限制潛在應用，並最終減緩市場發展，因為企業可能會優先考慮合規而非成長機會。

全球哺乳動物蛋白市場趨勢

全球哺乳動物蛋白市場正經歷重大變革，其主要驅動力是永續蛋白創新。製造商正日益採用環保的籌資策略，並致力於減少溫室氣體排放。在此背景下，對先進育種技術、廢棄物最小化和循環生物經濟模式的投資日益普及，使企業能夠從每件產品中獲取更大的價值。這一趨勢的主要驅動力是消費者對來源可靠的動物性成分日益成長的需求，以及企業對永續性目標的承諾。隨著供應鏈透明度的提高，那些優先考慮哺乳動物蛋白質生產永續實踐的企業正在確立自身的競爭優勢，並進一步增強相關人員的信任。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球哺乳動物蛋白市場規模：依蛋白質類型分類

• 生長因子
• 細胞激素
• 酵素
• 結構蛋白

全球哺乳動物蛋白市場規模：依來源分類

• 人類
• 牛
• 小鼠來源

全球哺乳動物蛋白市場規模：依應用領域分類

• 細胞培養
• 藥物發現
• 再生醫學
• 生物製藥生產

全球哺乳動物蛋白市場規模：依最終用戶分類

• 生技公司
• 製藥公司
• 研究機構

全球哺乳動物蛋白市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Merck KGaA
• Thermo Fisher Scientific Inc.
• Lonza Group AG
• Bio-Techne Corporation
• FUJIFILM Irvine Scientific, Inc.
• STEMCELL Technologies Inc.
• Corning Incorporated
• Sartorius AG
• CellGenix GmbH
• PromoCell GmbH
• Proteintech Group, Inc.
• Abcam plc
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Creative BioMart
• ACROBiosystems
• OriGene Technologies, Inc.
• PeproTech, Inc.
• Miltenyi Biotec BV & Co. KG
• Cyagen Biosciences Inc.

結論與建議

Global Mammalian Derived Proteins Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.37 Billion in 2025 to USD 4.62 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global market for mammalian derived proteins is characterized by proteins sourced from livestock like bovine serum albumin, collagen, and immunoglobulins, which play pivotal roles in pharmaceuticals, diagnostics, and cell-culture media due to their high compatibility with human biochemistry. This compatibility results in enhanced efficacy and reduced immunogenicity compared to recombinant proteins. The market, once constrained to academic settings, has expanded significantly, driven by innovations in purification technologies and a growing demand for biologics. The rapid increase in biopharmaceutical developments has heightened the need for serum-free, animal-compatible media, thereby boosting production of key proteins like collagen and albumin. This, in turn, lowers manufacturing costs, accelerates market entry for oncology products, and fosters investment in regenerative medicine applications, further propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mammalian Derived Proteins market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mammalian Derived Proteins Market Segments Analysis

Global mammalian derived proteins market is segmented by protein type, source, application, end user and region. Based on protein type, the market is segmented into growth factors, cytokines, enzymes and structural proteins. Based on source, the market is segmented into human, bovine and murine. Based on application, the market is segmented into cell culture, drug discovery, regenerative medicine and biopharmaceutical manufacturing. Based on end user, the market is segmented into biotechnology companies, pharmaceutical companies and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mammalian Derived Proteins Market

The demand for protein ingredients offering health advantages that extend beyond basic nutrition is on the rise among consumers. They are looking for proteins that support muscle recovery, boost immune function, and promote satiety. Mammalian derived proteins, recognized for their comprehensive amino acid profiles and bioactive peptides, meet these consumer expectations and are increasingly being integrated into various products, including snack bars, dairy substitutes, and fortified beverages. This trend fosters product innovation and broadens distribution networks, ultimately driving revenue growth as brands capitalize on the perceived added value and functional benefits of these proteins to stand out in a competitive marketplace.

Restraints in the Global Mammalian Derived Proteins Market

The Global Mammalian Derived Proteins market faces significant restraints due to the stringent regulations imposed by authorities in key regions. These regulations focus on safety, labeling, and animal welfare, all intended to safeguard public health and uphold ethical standards. Manufacturers must invest considerable time and resources into extensive validation studies, documentation for traceability, and undergoing routine audits. This not only extends the time required to bring products to market but also increases operational complexities. Additionally, the uncertainty surrounding changing regulations may hinder the launch of new products and restrict potential applications, as businesses prioritize compliance over growth opportunities, ultimately slowing market progress.

Market Trends of the Global Mammalian Derived Proteins Market

The global mammalian derived proteins market is undergoing a significant transformation driven by a robust trend towards sustainable protein innovation. Manufacturers are increasingly adopting environmentally friendly sourcing strategies and focusing on reducing their greenhouse gas emissions. In this context, investments in advanced breeding techniques, waste minimization, and circular bio-economy models are becoming prevalent, allowing companies to derive greater value from by-products. This movement is largely motivated by rising consumer demand for responsibly sourced animal-derived ingredients and corporate commitments to sustainability goals. As transparency in supply chains improves, firms that prioritize sustainable practices in mammalian protein production are establishing themselves as leaders in competitive differentiation and fostering stronger stakeholder trust.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Mammalian Derived Proteins Market Size by Protein Type & CAGR (2026-2033)

• Market Overview
• Growth Factors
• Cytokines
• Enzymes
• Structural Proteins

Global Mammalian Derived Proteins Market Size by Source & CAGR (2026-2033)

• Market Overview
• Human
• Bovine
• Murine

Global Mammalian Derived Proteins Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cell Culture
• Drug Discovery
• Regenerative Medicine
• Biopharmaceutical Manufacturing

Global Mammalian Derived Proteins Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Research Institutes

Global Mammalian Derived Proteins Market Size & CAGR (2026-2033)

• North America (Protein Type, Source, Application, End User)
  • US
  • Canada
• Europe (Protein Type, Source, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Protein Type, Source, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Protein Type, Source, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Protein Type, Source, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellGenix GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative BioMart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACROBiosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PeproTech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations